SenesTech (NASDAQ:SNES) Announces Earnings Results

Share on StockTwits

SenesTech (NASDAQ:SNES) posted its quarterly earnings data on Tuesday. The company reported ($0.09) EPS for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.01, Bloomberg Earnings reports. SenesTech had a negative net margin of 3,908.08% and a negative return on equity of 186.65%.

NASDAQ SNES opened at $1.41 on Wednesday. The stock has a 50 day moving average of $1.50. The company has a quick ratio of 2.76, a current ratio of 3.83 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $38.72 million, a price-to-earnings ratio of -2.23 and a beta of 1.76. SenesTech has a 52-week low of $0.55 and a 52-week high of $1.95.

Separately, ValuEngine raised shares of SenesTech from a “hold” rating to a “buy” rating in a research report on Friday, June 28th.

In related news, CEO Kenneth S. Siegel purchased 696,296 shares of SenesTech stock in a transaction dated Tuesday, July 16th. The stock was acquired at an average cost of $1.35 per share, with a total value of $939,999.60. Following the completion of the transaction, the chief executive officer now directly owns 702,558 shares of the company’s stock, valued at $948,453.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 10.91% of the stock is owned by corporate insiders.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. purchased a new stake in shares of SenesTech in the second quarter worth approximately $115,000. Bank of New York Mellon Corp purchased a new stake in shares of SenesTech in the second quarter worth approximately $62,000. MRA Associates USA LLC purchased a new stake in shares of SenesTech in the second quarter worth approximately $46,000. First Interstate Bank purchased a new stake in shares of SenesTech in the second quarter worth approximately $31,000. Finally, Meitav Dash Investments Ltd. purchased a new stake in shares of SenesTech in the first quarter worth approximately $81,000. 6.93% of the stock is owned by institutional investors and hedge funds.

About SenesTech

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment.

See Also: How to find the components of the quick ratio

Earnings History for SenesTech (NASDAQ:SNES)

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

James C. Blair Acquires 40,000 Shares of Clovis Oncology  Stock
James C. Blair Acquires 40,000 Shares of Clovis Oncology Stock
United Rentals, Inc.  Director Acquires $220,740.00 in Stock
United Rentals, Inc. Director Acquires $220,740.00 in Stock
Insider Buying: istar Inc  Major Shareholder Buys 7,500 Shares of Stock
Insider Buying: istar Inc Major Shareholder Buys 7,500 Shares of Stock
Colin Peter Kilty Sells 17,394 Shares of Parkland Fuel Corp  Stock
Colin Peter Kilty Sells 17,394 Shares of Parkland Fuel Corp Stock
Insider Selling: TFS Financial Co.  Chairman Sells 13,222 Shares of Stock
Insider Selling: TFS Financial Co. Chairman Sells 13,222 Shares of Stock
Insider Buying: istar Inc  Major Shareholder Acquires 7,500 Shares of Stock
Insider Buying: istar Inc Major Shareholder Acquires 7,500 Shares of Stock


© 2006-2019 Ticker Report